1. Home
  2. PRME vs DDI Comparison

PRME vs DDI Comparison

Compare PRME & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • DDI
  • Stock Information
  • Founded
  • PRME 2019
  • DDI 2008
  • Country
  • PRME United States
  • DDI South Korea
  • Employees
  • PRME N/A
  • DDI N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • DDI EDP Services
  • Sector
  • PRME Health Care
  • DDI Technology
  • Exchange
  • PRME Nasdaq
  • DDI Nasdaq
  • Market Cap
  • PRME 693.5M
  • DDI 472.2M
  • IPO Year
  • PRME 2022
  • DDI 2021
  • Fundamental
  • Price
  • PRME $4.67
  • DDI $9.34
  • Analyst Decision
  • PRME Buy
  • DDI Strong Buy
  • Analyst Count
  • PRME 6
  • DDI 5
  • Target Price
  • PRME $8.88
  • DDI $19.60
  • AVG Volume (30 Days)
  • PRME 2.9M
  • DDI 46.3K
  • Earning Date
  • PRME 11-11-2025
  • DDI 11-10-2025
  • Dividend Yield
  • PRME N/A
  • DDI N/A
  • EPS Growth
  • PRME N/A
  • DDI N/A
  • EPS
  • PRME N/A
  • DDI 2.15
  • Revenue
  • PRME $4,961,000.00
  • DDI $333,256,000.00
  • Revenue This Year
  • PRME $179.58
  • DDI $16.04
  • Revenue Next Year
  • PRME N/A
  • DDI $6.72
  • P/E Ratio
  • PRME N/A
  • DDI $4.35
  • Revenue Growth
  • PRME 739.42
  • DDI 0.24
  • 52 Week Low
  • PRME $1.11
  • DDI $8.09
  • 52 Week High
  • PRME $5.17
  • DDI $18.21
  • Technical
  • Relative Strength Index (RSI)
  • PRME 67.60
  • DDI 43.75
  • Support Level
  • PRME $3.09
  • DDI $9.20
  • Resistance Level
  • PRME $4.18
  • DDI $9.74
  • Average True Range (ATR)
  • PRME 0.31
  • DDI 0.22
  • MACD
  • PRME 0.11
  • DDI -0.02
  • Stochastic Oscillator
  • PRME 98.14
  • DDI 14.89

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: